Skip to main content

SB 2796

AN ACT relating to the Cancer Prevention Research Institute's fiscal

Senate Bill Hughes
Filed

Filed

Bill introduced by legislator

Committee

Hearing

Passed Cmte

Calendar

Passed

Sent

Enrolled

Governor

Signed

89th Regular Session

Jan 14, 2025 - Jun 2, 2025 • Session ended

Awaiting Committee Assignment

Bill filed, pending referral to Senate committee

← Back to Bills

Committee

Not yet assigned

Fiscal Note

Not available

What This Bill Does

relating to the Cancer Prevention Research Institute's fiscal

Subject Areas

Bill Text

relating to the Cancer Prevention Research Institute's fiscal
responsibilities to the state of Texas.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.  Section 102.002, Health and Safety Code, is
Sec. 102.002.  PURPOSES.  The Cancer Prevention and Research
Institute of Texas is established to:
(1)  create and expedite innovation in the area of
cancer research and in enhancing the potential for a medical
or scientific breakthrough in the prevention of cancer and
(2)  attract, create, or expand research capabilities
of public or private institutions of higher education and
other public or private entities that will promote a
substantial increase in cancer research and in the creation
of high-quality new jobs in this state; and
(3)  develop and implement the Texas Cancer Plan.; and
(4)  provide a reasonable return on investment for the
state, with fiduciary responsibilities to the state of Texas,
with a non-binding target of at least 1% returns per year,
subject to the decision of the Institute's oversight
SECTION 2.  Section 102.0511(c), Health and Safety Code, is
(c)  The chief executive officer shall hire:
(1)  one chief scientific officer;
(2)  one chief operating officer;
(3)  one chief investment officer;
(34) one chief product development officer; and
(45) one chief prevention officer.
SECTION 3.  Section 102.251(a-2-C), Health and Safety Code,
(C)  to the extent possible, gives priority to
(i)  could lead to immediate or long-term medical
and scientific breakthroughs in the area of cancer
prevention or cures for cancer;
(ii)  strengthen and enhance fundamental science
(iii)  ensure a comprehensive coordinated
(iv)  to the best of the program integration
committee's knowledge, with consultation by the chief
investment officer and chief financial officer, is
expected to be financially viable and to enter the
market within 15 years of initial investment, provide a
complete return on initial investment for the state
within 20 years, as long as a grant is considered by the
program integration committee to be of extraordinary
(ivv)  are interdisciplinary or
(vi)  address federal or other major research
sponsors' priorities in emerging scientific or
technology fields in the area of cancer prevention or
(vii)  are matched with funds available by a
private or nonprofit entity and institution or
institutions of higher education;
(viii)  are collaborative between any combination
of private and nonprofit entities, public or private
agencies or institutions in this state, and public or
private institutions outside this state;
(viiiix)  have a demonstrable economic
development benefit to this state;
(ix)  enhance research superiority at
institutions of higher education in this state by
creating new research superiority, attracting existing
research superiority from institutions not located in
this state and other research entities, or enhancing
existing research superiority by attracting from
outside this state additional researchers and
(xi)  expedite innovation and product
development, attract, create, or expand private sector
entities that will drive a substantial increase in
high-quality jobs, and increase higher education
applied science or technology research capabilities;
(xii)  address the goals of the Texas Cancer Plan;
SECTION 4.  Section 102.255 (c-3), Health and Safety Code,
(A)  the amount of matching funds to be dedicated
(B)  the period in which the grant award must be
(C)  the name of the research project to which
matching funds are to be dedicated; and
(D)  the specific deliverables of the project that
is the subject of the grant proposal.; and
(E)  an agreement by the grant recipient to
provide bi-annual reports on the anticipated timeline
for a return on investment for the state's portion of
the grant money, when taking into consideration the
progress made by grant recipient and market conditions.
SECTION 5.  This Act takes effect immediately if it receives
a vote of two-thirds of all the members elected to each house, as
provided by Section 39, Article III, Texas Constitution.  If this
Act does not receive the vote necessary for immediate effect, this
Act takes effect September 1, 2025.

Bill History

filed

Bill filed: AN ACT relating to the Cancer Prevention Research Institute's fiscal